174 related articles for article (PubMed ID: 16149611)
21. [Tumor-associated trypsin inhibitor--an expanded tumor marker spectrum in cervix cancer?].
Medl M; Ogris E; Fuchs G; Leodolter S
Gynakol Rundsch; 1990; 30 Suppl 1():118-21. PubMed ID: 2079243
[No Abstract] [Full Text] [Related]
22. Early predicting recurrent cervical cancer with combination of tissue polypeptide specific antigen (TPS) and squamous cell carcinoma antigen (SCC).
Hung YC; Shiau YC; Chang WC; Kao CH; Lin CC
Neoplasma; 2002; 49(6):415-7. PubMed ID: 12584591
[TBL] [Abstract][Full Text] [Related]
23. [The importance of the SCC antigen in the diagnosis and follow-up of cervix carcinoma. A cooperative study of the Gynecologic Tumor Marker Group (GTMG)].
Crombach G; Würz H; Herrmann F; Kreienberg R; Möbus V; Schmidt-Rhode P; Sturm G; Caffier H; Kaesemann H
Dtsch Med Wochenschr; 1989 May; 114(18):700-5. PubMed ID: 2714197
[TBL] [Abstract][Full Text] [Related]
24. [CA15-3].
Inaji H
Nihon Rinsho; 2005 Aug; 63 Suppl 8():651-3. PubMed ID: 16149603
[No Abstract] [Full Text] [Related]
25. Squamous cell carcinoma antigen in oral squamous cell carcinomas.
Nagumo K; Okada N; Takagi M; Yamamoto H; Amagasa T; Fujibayashi T
Bull Tokyo Med Dent Univ; 1990 Jun; 37(1-2):27-34. PubMed ID: 2225283
[TBL] [Abstract][Full Text] [Related]
26. [Squamous cell carcinoma antigen].
Nawata S; Sugino N; Kato H
Nihon Rinsho; 2010 Jul; 68 Suppl 7():729-31. PubMed ID: 20960858
[No Abstract] [Full Text] [Related]
27. Study of a new tumor marker, CYFRA 21-1, in squamous cell carcinoma of the cervix, and comparison with squamous cell carcinoma antigen.
Tsai SC; Kao CH; Wang SJ
Neoplasma; 1996; 43(1):27-9. PubMed ID: 8843956
[TBL] [Abstract][Full Text] [Related]
28. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.
Reesink-Peters N; van der Velden J; Ten Hoor KA; Boezen HM; de Vries EG; Schilthuis MS; Mourits MJ; Nijman HW; Aalders JG; Hollema H; Pras E; Duk JM; van der Zee AG
J Clin Oncol; 2005 Mar; 23(7):1455-62. PubMed ID: 15735121
[TBL] [Abstract][Full Text] [Related]
29. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen.
Bonfrer JM; Gaarenstroom KN; Korse CM; Van Bunningen BN; Kenemans P
Anticancer Res; 1997; 17(3C):2329-34. PubMed ID: 9245246
[TBL] [Abstract][Full Text] [Related]
30. Molecular detection of circulating esophageal squamous cell cancer cells in the peripheral blood.
Koike M; Hibi K; Kasai Y; Ito K; Akiyama S; Nakao A
Clin Cancer Res; 2002 Sep; 8(9):2879-82. PubMed ID: 12231531
[TBL] [Abstract][Full Text] [Related]
31. Determining the concentrations of the squamous cell carcinoma antigen using the Maglumi 2000 automatic analyzer.
Ni X; Qi S
Minerva Med; 2014 Feb; 105(1):57-61. PubMed ID: 24184959
[TBL] [Abstract][Full Text] [Related]
32. [Tumor markers in uterine cancers].
Fukasawa I; Kousaka N; Kun Z; Inaba N
Gan To Kagaku Ryoho; 2002 Feb; 29(2):333-40. PubMed ID: 11865645
[TBL] [Abstract][Full Text] [Related]
33. The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients.
Mroczko B; Kozłowski M; Groblewska M; Łukaszewicz M; Nikliński J; Jelski W; Laudański J; Chyczewski L; Szmitkowski M
Clin Chim Acta; 2008 Mar; 389(1-2):61-6. PubMed ID: 18155162
[TBL] [Abstract][Full Text] [Related]
34. Granulocyte colony stimulating factor-producing collision tumor of the gastric cardia.
Komatsu D; Sakurai M; Nakafuji H; Koide N; Morishita H; Nakamura T
J Gastroenterol; 2003; 38(10):1013-5. PubMed ID: 14614613
[No Abstract] [Full Text] [Related]
35. [The course of squamous cell cancer antigen in chemotherapy as a prognostic criterion in cervix cancer].
Meier W; Stieber P; Fateh-Moghadam A; Eiermann W; Hepp H
Gynakol Rundsch; 1989; 29 Suppl 2():411-2. PubMed ID: 2613066
[No Abstract] [Full Text] [Related]
36. [Fundamental and clinical evaluation of "SCC RIABEAD" kit for immunoradiometric assay of squamous cell carcinoma related antigen].
Koizumi M; Endo K; Nakajima K; Sakahara H; Kawamura Y; Watanabe Y; Saga T; Kunimatsu M; Konishi J; Matsui Y
Kaku Igaku; 1987 Nov; 24(11):1693-700. PubMed ID: 3446911
[No Abstract] [Full Text] [Related]
37. [Squamous cell carcinoma antigen levels in patients with laryngeal cancer].
Polberg K; Stepulak A; Stryjecka-Zimmer M; Kupisz K; Zawiślak J
Pol Merkur Lekarski; 2005 Sep; 19(111):375-6. PubMed ID: 16358876
[TBL] [Abstract][Full Text] [Related]
38. [DU-PAN-2, SPan-1].
Motoo Y; Sawabu N
Nihon Rinsho; 2005 Aug; 63 Suppl 8():687-90. PubMed ID: 16149612
[No Abstract] [Full Text] [Related]
39. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
Gaarenstroom KN; Kenter GG; Bonfrer JM; Korse CM; Van de Vijver MJ; Fleuren GJ; Trimbos JB
Gynecol Oncol; 2000 Apr; 77(1):164-70. PubMed ID: 10739706
[TBL] [Abstract][Full Text] [Related]
40. The value of squamous cell carcinoma antigen as a predictor of nodal metastasis in cervical cancer.
Takeshima N; Hirai Y; Katase K; Yano K; Yamauchi K; Hasumi K
Gynecol Oncol; 1998 Mar; 68(3):263-6. PubMed ID: 9570978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
